2030年亚太地区临床前成像市场规模及挑战

亚太临床前成像市场分析和规模

亚太临床前成像市场是提供成像解决方案和技术的行业，用于在药物开发和医学研究的临床前阶段对动物（通常是啮齿动物）进行研究和实验。这些成像技术对于在潜在候选药物和医疗治疗进入涉及人类的临床试验之前评估其安全性和有效性至关重要。临床前成像使研究人员和制药公司能够在进入人体试验之前评估候选药物对生物体的影响。这有助于识别潜在问题，优化给药方案，并降低后期出现不良反应的风险。

Data Bridge Market Research 分析称，亚太地区临床前成像市场价值预计将从 2022 年的 264,195.80 万美元增至 2030 年的 396,436.69 万美元，预测期内的复合年增长率为 5.5%。

报告指标	细节
预测期	2023 至 2030 年
基准年	2022
历史岁月	2021 (可定制为 2015-2020)
定量单位	收入（千美元）
涵盖的领域	产品（系统和服务）、试剂（临床前光学成像试剂、临床前核成像试剂、临床前 MRI 造影剂、临床前超声造影剂和临床前 CT 造影剂）、应用（研发、药物发现、生物分布、癌细胞检测、生物标志物等）、最终用户（合同研究组织、制药和生物技术公司、学术和政府研究机构、诊断中心等）
覆盖国家	日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太地区其他地区
涵盖的市场参与者	PerkinElmer Inc.、FUJIFILM Visualsonics, Inc（富士胶片株式会社的子公司）、Bruker、Hologic, Inc.、蔡司集团、安捷伦科技公司、Hamamatsu Photonics KK、Vieworks Co., Ltd.、LI-COR, Inc.、Berthold Technologies GmbH & Co.KG、MILabs BV、Trifoil Imaging、Mediso Ltd.、IVIM Technology Inc.、MR Solutions、AI4R 等

市场定义

临床前成像是使用各种成像技术在动物模型中进行可视化和研究生物过程、疾病和药物反应，然后再进行人体测试。它涉及对动物（通常是啮齿动物，如小鼠和大鼠）进行非侵入性成像，以深入了解疾病的潜在机制并评估潜在疗法的有效性和安全性。

亚太临床前成像市场动态

驱动程序

不断提高成像领域的技术进步

成像领域的技术进步在推动亚太临床前成像市场增长方面发挥着至关重要的作用。高分辨率磁共振成像 (MRI)、微型计算机断层扫描 (micro-CT) 和先进超声波等现代成像技术为研究人员提供了更清晰、更详细的生物结构图像。

此外，图像分析和数据处理算法也得到了显著改进。先进的软件工具和机器学习算法使研究人员能够从图像中提取定量数据，自动执行图像处理任务，并提高数据分析的准确性和效率。这些进步节省了时间，并提高了临床前研究的可重复性和可靠性。

研发投资和资金不断增加

研发 (R&D) 领域的投资和资金不断增加是推动亚太地区临床前成像市场增长的重要因素。随着临床前成像在药物发现和开发中的重要性日益凸显，各组织正在投入大量资源来推进成像技术并支持创新研究计划。

研发投资和资金支持开发新型临床前成像模式和技术。这些资金支持促进了成像系统、软件和硬件的改进，从而提高了图像质量、分辨率和灵敏度。这些进步使研究人员能够获得有关生物过程、疾病机制和治疗反应的更准确和详细的信息，从而推动了临床前成像市场的增长。

机会

越来越多地采用成像系统进行临床前研究

制药和生物技术行业不断寻找新型候选药物，以满足尚未满足的医疗需求。临床前成像可通过可视化潜在候选药物对生物体的影响，更全面地了解这些药物。这有助于在药物开发过程的早期识别有希望的候选药物并排除具有不良特征的候选药物，从而节省时间和资源。个性化医疗的转变需要更彻底地了解个体患者的病情。临床前成像可用于评估疾病异质性并定制治疗方法，从而实现更有效的疗法。

克制/挑战

严格的产品审批监管框架

全球各地的监管机构对于临床前成像产品的审批都制定了严格的指导方针和要求，这可能会给市场中的企业设置障碍，是亚太地区临床前成像市场增长的重要制约因素。

临床前成像产品的监管流程耗时长且成本高昂。公司需要进行全面的研究来证明其产品的安全性和有效性，这需要大量研发投资。此外，监管提交流程需要大量文档、数据分析和与监管机构的互动，所有这些都增加了时间和成本负担。

最新动态

2022 年 11 月，布鲁克宣布收购 Inscopix, Inc.，这是一家神经科学先驱和微型显微镜（称为微型显微镜）的市场领导者，用于自由移动的动物大脑成像。这有助于该组织创造更多收入
2022 年 5 月，富士胶片公司宣布推出 Vevo F2，这是世界上第一款用于临床前用途的超高至低频 (71MHz-1MHz) 超声和光声成像系统。Vevo F2 采用高清图像处理技术，并引入了全新的信号通路——从传感器到显示屏。这提高了图像清晰度，与多线处理相结合，与上一代平台相比，帧速率显著提高

亚太临床前成像市场范围

亚太临床前成像市场根据产品、试剂、应用和最终用户分为四个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品

系统
服务

根据产品，市场分为系统和服务。

试剂

临床前光学成像试剂
临床前核成像试剂
临床前 MRI 造影剂
临床前超声造影剂
临床前 CT 造影剂

根据试剂，市场细分为临床前光学成像试剂、临床前核成像试剂、临床前 MRI 造影剂、临床前超声造影剂和临床前 CT 造影剂。

应用

研究与开发
药物研发
生物分布
癌细胞检测
生物标志物
其他的

根据应用，市场分为研究和开发、药物发现、生物分布、癌细胞检测、生物标志物等。

最终用户

合同研究组织
制药和生物科技公司
学术及政府研究机构
诊断中心
其他的

根据最终用户，市场分为合同研究组织、制药和生物技术公司、学术和政府研究机构、诊断中心等。

亚太临床前成像市场区域分析/见解

根据产品、试剂、应用和最终用户，亚太临床前成像市场分为四个显著的部分。

本市场报告涵盖的国家包括日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾和亚太其他地区。

由于对成像设备的需求不断增长，预计中国将占据市场主导地位。由于技术进步不断加快，中国是市场增长最快的国家，市场份额最大。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了区域品牌的存在和可用性以及由于区域品牌的竞争激烈或稀缺而面临的挑战、国内关税的影响和贸易路线。

竞争格局和亚太临床前成像市场份额分析

临床前成像市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

亚太地区临床前成像市场的一些主要市场参与者包括 PerkinElmer Inc.、FUJIFILM Visualsonics, Inc（富士胶片株式会社的子公司）、Bruker、Hologic, Inc.、蔡司集团、安捷伦科技公司、滨松光子学株式会社、Vieworks Co., Ltd.、LI-COR, Inc.、Berthold Technologies GmbH & Co.KG、MILabs BV、Trifoil Imaging、Mediso Ltd.、IVIM Technology Inc.、MR Solutions、AI4R 等。

SKU-70323

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 2 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 3 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 4 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 5 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 6 ASIA-PACIFIC PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 7 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 13 CHINA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 14 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 15 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 16 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 17 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 18 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 19 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 20 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 21 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 22 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 23 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 24 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 25 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 26 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 27 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 28 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 29 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 30 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 31 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 32 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 33 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 34 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 35 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 36 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 37 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 38 CHINA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 39 CHINA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 40 JAPAN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 41 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 42 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 43 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 44 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 45 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 46 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 47 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 48 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 49 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 50 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 51 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 52 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 53 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 54 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 55 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 56 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 57 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 58 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 59 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 60 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 61 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 62 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 63 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 64 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 65 JAPAN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 66 JAPAN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 67 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 68 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 69 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 70 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 71 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 72 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 73 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 74 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 75 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 76 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 77 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 78 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 79 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 80 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 81 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 82 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 83 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 84 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 85 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 86 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 87 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 88 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 89 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 90 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 91 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 92 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 93 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 94 INDIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 95 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 96 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 97 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 98 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 99 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 100 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 101 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 102 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 103 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 104 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 105 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 106 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 107 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 108 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 109 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 110 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 111 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 112 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 113 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 114 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 115 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 116 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 117 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 118 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 119 INDIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 120 INDIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 121 AUSTRALIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 122 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 123 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 124 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 125 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 126 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 127 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 128 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 129 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 130 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 131 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 132 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 133 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 134 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 135 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 136 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 137 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 138 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 139 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 140 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 141 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 142 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 143 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 144 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 145 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 146 AUSTRALIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 147 AUSTRALIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 148 SINGAPORE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 149 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 150 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 151 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 152 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 153 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 154 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 155 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 156 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 157 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 158 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 159 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 160 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 161 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 162 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 163 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 164 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 165 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 166 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 167 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 168 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 169 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 170 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 171 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 172 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 173 SINGAPORE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 174 SINGAPORE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 175 THAILAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 176 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 177 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 178 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 179 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 180 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 181 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 182 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 183 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 184 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 185 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 186 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 187 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 188 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 189 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 190 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 191 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 192 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 193 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 194 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 195 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 196 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 197 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 198 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 199 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 200 THAILAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 201 THAILAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 202 MALAYSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 203 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 204 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 205 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 206 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 207 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 208 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 209 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 210 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 211 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 212 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 213 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 214 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 215 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 216 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 217 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 218 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 219 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 220 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 221 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 222 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 223 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 224 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 225 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 226 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 227 MALAYSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 228 MALAYSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 229 INDONESIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 230 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 231 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 232 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 233 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 234 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 235 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 236 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 237 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 238 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 239 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 240 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 241 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 242 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 243 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 244 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 245 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 246 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 247 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 248 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 249 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 250 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 251 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 252 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 253 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 254 INDONESIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 255 INDONESIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 256 PHILIPPINES PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 257 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 258 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 259 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 260 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 261 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 262 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 263 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 264 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 265 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 266 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 267 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 268 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 269 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 270 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 271 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 272 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 273 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 274 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 275 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 276 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 277 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 278 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 279 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 280 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 281 PHILIPPINES PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 282 PHILIPPINES PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 283 REST OF ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

图片列表

FIGURE 1 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SEGMENTATION

FIGURE 11 THE RISING PREVALENCE OF CHRONIC DISORDERS AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE DRIVING THE GROWTH OF THE ASIA-PACIFIC PRECLINICAL IMAGING MARKET FROM 2023 TO 2030

FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRECLINICAL MARKET IN 2023 AND 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC PRECLINICAL IMAGING MARKET

FIGURE 14 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022

FIGURE 15 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)

FIGURE 16 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022

FIGURE 19 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, 2023-2030 (USD THOUSAND)

FIGURE 20 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, CAGR (2023-2030)

FIGURE 21 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, LIFELINE CURVE

FIGURE 22 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022

FIGURE 23 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 24 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, 2022

FIGURE 27 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 28 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SNAPSHOT (2022)

FIGURE 31 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

How big is the Asia-Pacific preclinical imaging market?

The Asia-Pacific preclinical imaging market size will be worth USD 396,436.69 thousand by 2030.

What is the growth rate of the Asia-Pacific preclinical imaging market?

The growth rate of the Asia-Pacific preclinical imaging market is 5.5% in the forecast by 2030.

What are the growth drivers of the Asia-Pacific preclinical imaging market?

Increasing technological advancement in the field of imaging & increasing number of investments and funding in research and development are the growth drivers of the Asia-Pacific preclinical imaging market.

What are the factors on which the Asia-Pacific preclinical imaging market research is based on?

Product, reagents, application, and end user are the factors on which the Asia-Pacific preclinical imaging market research is based.

Which are the major companies in the Asia-Pacific preclinical imaging market?

Major companies in the Asia-Pacific preclinical imaging market are PerkinElmer Inc., FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation), Bruker, Hologic, Inc., ZEISS Group, Agilent Technologies, Inc., Hamamatsu Photonics K.K., Vieworks Co., Ltd., LI-COR, Inc., Berthold Technologies GmbH & Co.KG, MILabs B.V., Trifoil Imaging, Mediso Ltd., IVIM Technology Inc., MR Solutions, AI4R and among others.

Forecast Period	2023 –2030
Market Size (Base Year)	USD 264,195.80 Thousand
Market Size (Forecast Year)	USD 396,436.69 Thousand
CAGR	5.50 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

亚太临床前成像市场 – 行业趋势和 2030 年预测

亚太临床前成像市场 – 行业趋势和 2030 年预测

Asia Pacific Preclinical Imaging Market

CAGR : 5.50 %

亚太临床前成像市场分析和规模

亚太临床前成像市场动态

亚太临床前成像市场范围

亚太临床前成像市场区域分析/见解

竞争格局和亚太临床前成像市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

亚太临床前成像市场 – 行业趋势和 2030 年预测

亚太临床前成像市场 – 行业趋势和 2030 年预测

Asia Pacific Preclinical Imaging Market

CAGR : 5.50 %

亚太临床前成像市场分析和规模

亚太临床前成像市场动态

亚太临床前成像市场范围

亚太临床前成像市场区域分析/见解

竞争格局和亚太临床前成像市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面